Revisiting clinical trial design – more adaptability in Phase I – III?
Elihu H. Estey
Phase III trial shows vosaroxin improves overall survival in acute myeloid leukaemia
Tackling unmet needs in lymphoma
Involving patients in clinical trial design: a message to academia and industry
Managing transplant ineligible AML patients